Background/Aims: Hypoxia is a powerful stimulator of angiogenesis under physiological as well as pathological conditions. Normal endothelial cells (EC), such as human umbilical vein EC (HUVEC), are relatively affected by hypoxic insult in terms of cell survival. In contrast, EC from tumors are particularly resistant to hypoxia-induced cell death. Previous reports have shown that EC in bone marrow from multiple myeloma (MM) patients had a hypoxic phenotype, even under normoxic conditions. The aim of this study was to evaluate whether HUVEC and MMEC adapt differently to hypoxia. Methods: Cell proliferation was assessed by the CyQUANT assay. Cdc25A, p21, Bax, Bcl-xl, BNIP3, glucose transporter (GLUT)-1, monocarboxylate transporter (MCT)-4 and carbonic anhydrase (CA)IX mRNA expression was determined by qRT-PCR. HIF-1α, BNIP3, Beclin-1, LC3B, livin, Bax, Bcl-xl, p21, p62 and β-actin protein expression was analyzed by western blot. Apoptosis was determined by TUNEL assay. Silencing of BNIP3 was achieved by stealth RNA system technology. Results: While HUVEC survival was reduced after prolonged hypoxic exposure, MMEC were completely unaffected. This difference was also significant in terms of livin, cdc25A and p21 expression. Hypoxia induced apoptosis and inhibited autophagy in HUVEC, but not in MMEC, where hypoxic treatment resulted in a more sustained adaptive response. In fact, MMEC showed a more significant increase in the expression of genes regulated transcriptionally by hypoxia-inducible factor (HIF)-1α. Interestingly, they showed higher expression of BNIP3 than did HUVEC, indicating a more pronounced autophagic (and pro-survival) phenotype. The potential role of BNIP3 in EC survival was confirmed by BNIP3 siRNA experiments in HUVEC, where BNIP3 inhibition resulted in reduced cell survival and increased apoptosis. Conclusion: These findings provide further information on how hypoxia may affect EC survival and could be important for a better understanding of EC physiology under normal and pathological conditions, such as in multiple myeloma.
Different Adaptive Responses to Hypoxia in Normal and Multiple Myeloma Endothelial Cells
Irene 
Introduction
Hypoxia is a common feature in various physiological and pathological conditions [1] . Different types of cells may adapt differently to hypoxia by modulating gene expression through the transcription factor hypoxia-inducible factor (HIF)-1 to overcome oxygen shortage [2] . HIF-1 is an αβ-heterodimer and HIF-α and HIF-β subunits exist as a series of isoforms encoded by distinct genetic loci [3] . HIF-1β can dimerize with different basic helix-loop-helix-PAS proteins and is constitutive, while HIF-α subunits are induced by hypoxia. Of the three HIF-α isoforms, HIF-1α is the primary source of hypoxic transcriptional response [4, 5] , which involves interacting with hypoxia response elements (HREs) to induce transcriptional activity [6] .
The role of the HIF pathway in cell death is controversial; HIF-1 can induce apoptosis and autophagy, prevent cell death, or even stimulate cell proliferation. Indeed, HIF-1α activates transcription of genes encoding Bcl-2/adenovirus E1B 19-kDa interacting protein 3 (BNIP3), which triggers selective autophagy [7] . Interdependence between autophagy and apoptosis seems to depend on cell type and the cellular environment. However, it has been clearly demonstrated that autophagy is a basic mechanism for maintaining cellular homeostasis, as well as a survival strategy [8, 9] .
With regard to cell death, endothelial cells (EC) are less susceptible than other cell types to hypoxic stress [10] . They tend to adapt better to hypoxia in terms of cell survival [11] . Furthermore, EC of tumor vessels differ greatly from those of quiescent healthy vessels [12] : they proliferate rapidly, in keeping with the enhanced angiogenesis associated with tumor progression (growth, invasion and metastasis). Their survival not only depends on the growth factors (and their receptors) in the tumor microenvironment, but also on hypoxia [13] .
Previous reports have shown that bone marrow angiogenesis is a constant hallmark of progression of multiple myeloma (MM) [14] . Indeed, MM endothelial cells (MMEC) play a crucial role in MM progression and HIF-1α protein is reported to be expressed constitutively and activated in MMEC in a well-defined proportion of patients experiencing relapse or refractory to treatment. More importantly, patients with MMEC expressing the HIF-1α protein have shorter overall survival [15] .
Although the pro-angiogenic role of HIF-1α has already been established in MM [15, 16] , to our knowledge no studies have documented MMEC adaptive response to hypoxia in terms of survival, apoptosis and/or autophagy. We therefore decided to investigate and compare the effects of hypoxia on bone marrow EC of active multiple myeloma patients and on healthy quiescent EC, namely human umbilical vein EC (HUVEC).
Materials and Methods
Cell culture and hypoxic treatment HUVEC and appropriate growth medium were purchased from Lonza (Walkersville, MD, USA) and cultured with 10% FBS, as indicated by the manufacturer. Bone marrow primary multiple myeloma endothelial cells (MMEC) were obtained as previously described [14] and cultured in Dulbecco's Modified Eagle's Medium (DMEM) (Euroclone, Devon, UK) supplemented with 20% FBS. The experiments, conducted under aerobic conditions, were performed using an incubator (VWR International PBI, Milano, Italy) set at 5% CO 2 , 20% O 2 (atmospheric oxygen ≈ 140 mmHg) and 37°C in a humidified environment. The experiments under hypoxic conditions were performed using a workstation InVivo 400 (Ruskinn, Pencoed, UK) which provides a stable customized humidified environment through electronic control of CO 2 (5%), O 2 and temperature (37°C). In our experiments, O 2 was set and maintained constantly at 2% (≈ 14 mmHg) by injecting N 2 automatically into the chamber, as previously described [17] . Cells were plated and allowed to adhere overnight. The next morning they were incubated in normoxia or hypoxia for the indicated times. At the end of the experiments, the cells were analyzed as follows.
Cell proliferation assay
Cell proliferation was assessed with the CyQUANT Kit (Molecular Probe, Eugene, OR, USA), according to the manufacturer's instructions, as previously described [18] . Cells (2x10 4 cells/ml) were exposed to normoxia or hypoxia for 8-24-48 h. Fluorescence was measured using a microplate reader (FluostarOptima, BMG LABTECH, Durham, NC, USA).
RNA preparation and real-time PCR
Cdc25A, p21(p21/WAF1), Bax, Bcl-xl, BNIP3, glucose transporter (GLUT)-1, monocarboxylate transporter (MCT)-4 and carbonic anhydrase (CA)IX mRNA expression was determined by real-time PCR using an iQ TM 5 Multicolor Real-Time PCR Detection System (Bio-Rad Laboratories, Hercules, CA, USA) as previously described [17] . Briefly, total RNA was extracted from normoxic or hypoxic cells using the TRI Reagent ® (Ambion, Austin, TX, USA). First-strand cDNA was synthesized using an iScript TM cDNA Synthesis Kit (Bio-Rad Laboratories). qRT-PCR was performed using iTaq TM SYBR Green Supermix (Bio-Rad Laboratories) and the specific primers were designed by the Primer-BLAST program (available at https://blast.ncbi.nlm. nih.gov). Thermocycler conditions included an initial hold at 95°C for 30 sec, followed by a two-step PCR program: 95°C for 10 sec and 60°C for 30 sec for 49 cycles. CAIX mRNA expression was determined by TaqMan-Based Multiplex real-time PCR. p21 (p21/WAF1), Bax, Bcl-xl, BNIP3, GLUT-1 and MCT-4 primers were purchased from Invitrogen (Paysley, UK), while Cdc25A and CAIX primers and TaqMan probes were obtained from Eurofins Genomics (Ebersberg, Germany). Data were analyzed quantitatively with iQ TM 5 Optical System Software (Bio-Rad Laboratories). Relative quantification was done using the 2 -ΔΔCT method [19] and β-actin was used as housekeeping control. The specificity of PCR amplification of each primer pair was confirmed analyzing PCR products by agarose gel electrophoresis and melting curve analysis.
Western blot analysis
For western blot analysis, cells were promptly processed to avoid culture reoxygenation, appropriately lysed and analyzed using antibodies against HIF-1α (BD Biosciences, San Jose, CA), BNIP3 (Thermo Scientific, Rockford, IL, USA), Beclin-1, LC3B, p62, Bax, Bcl-xl and β-actin (Cell Signaling, Danvers, MA, USA) and p21 (p21/WAF1; Oncogene Research Products, San Diego, CA). Chemiluminescence was detected and quantified using a ChemiDoc XRS apparatus and Quantity One software (Bio-Rad Laboratories) as previously described [17] .
Human apoptosis array
Analysis of livin protein expression was performed with a Human Apoptosis Array kit (R&D Systems, Minneapolis, MN, USA). Both normoxic and hypoxic cells were lysed in the appropriate buffer at 2-8°C for 30 min and processed according to the manufacturer's instructions. Chemiluminescence was detected by ChemiDoc XRS/Quantity One software (Bio-Rad Laboratories) and quantitative evaluation was based on pixel densities, which were calculated and normalized to reference spots, as indicated by the manufacturer.
TUNEL Assay
Apoptosis was determined on cells exposed to normoxia or hypoxia for 48 h. A terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay was conducted using an HT Titer-TACS™ assay kit (Trevigen, Gaithersburg, MD, USA) according to the manufacturer's protocol. TUNEL-positive cells were measured at absorbance 450 nm using a Multiskan EX 96-well plate reader (Thermo Scientific, Rockford, IL, USA) after addition of 0.2 N HCl. As positive control, cells were treated with TACS-nuclease, supplied with the assay kit, for 1 h at 37°C before hydrogen peroxide treatment.
BNIP3 siRNA
Silencing of BNIP3 was achieved by stealth RNA system technology (Invitrogen). The siRNA target sequences are Exon 2 (NM_004052) of human BNIP3 mRNA; negative controls were designed with the same CG ratio without any known human genome target. HUVEC were transfected in suspension using Neon™ Transfection System (Invitrogen) according to the manufacturer's instructions and incubated for 24 h with stealth RNA at a concentration of 50 nM. Following transfection, cells were exposed to normoxia or hypoxia for 48 h. Real-time PCR, western blot analysis, cell proliferation and apoptosis were conducted as described above.
Results

Hypoxia affects HUVEC and MMEC proliferation differently
Although HUVEC proliferation was relatively affected by hypoxia, MMEC were completely resistant. The HUVEC viability assay revealed an apparent reduction in cell proliferation after 24 h of continuous exposure to an oxygen partial pressure of 14 mmHg (Fig. 1a) . The reduction became statistically significant after 48 h of hypoxic treatment. In contrast, MMEC proliferation was not affected by 24 h of hypoxia, or even 48 h of continuous exposure. HUVEC and MMEC proliferation patterns under hypoxia were evaluated by several techniques. The human apoptosis array kit revealed significant enhancement of expression of the protein livin (an apoptosis inhibitor) in MMEC exposed to hypoxia for 48 h, in contrast with HUVEC (Fig. 1b) . We also determined the expression of cdc25A, a member of the cdc25 family of phosphatases, which is required for progression from G1 to the S phase of the cell cycle. As shown in Fig. 1c, cdc25A mRNA expression was significantly enhanced in hypoxic MMEC, and significantly reduced in HUVEC. In contrast, mRNA and protein expression of the cyclin-dependent kinase inhibitor 1, p21, was significantly enhanced in HUVEC and reduced in MMEC, confirming resistance of MMEC to hypoxic insult (Fig. 1d) .
MMEC are more resistant to hypoxia-induced cell death than HUVEC Since HUVEC and MMEC viabilities were differently affected by hypoxia, we decided to evaluate the mechanism involved. Cell death was analyzed by different approaches to determine whether it was related to apoptosis.
To detect cell apoptosis, DNA fragmentation was evaluated by TUNEL assay on HUVEC and MMEC exposed to hypoxia. In HUVEC, 48 h exposure induced a significant increase in the percentage of apoptotic cells, whereas MMEC were unaffected (Fig. 2a) . Since the ratio of Bax to Bcl-xl expression is an index of apoptosis, we calculated it at mRNA and protein levels by realtime PCR and western blot analysis. With the TUNEL assay results, 48 h exposure to hypoxia enhanced the Bax/Bcl-xl ratio at mRNA and protein levels in HUVEC, whereas it was significantly reduced in MMEC (Fig. 2b) . This indicates that HUVEC are more prone to apoptosis than MMEC under hypoxia. Finally, we decided to investigate whether hypoxia affects expression of proautophagic markers, such as Beclin-1 and LC3B-I and -II, in different ways (Fig. 2c) . Interestingly, 48 h exposure to hypoxia resulted in a significant reduction in Beclin-1 expression in HUVEC. We also observed a similar reduction in the LC3B-II/ LC3B-I ratio, indicating an impaired autophagic process. In contrast, hypoxia did not affect expression of these autophagic markers in MMEC. For a better characterization of autophagy, we also evaluated expression of p62, a protein whose degradation is normally associated with autophagic flux [20] . In our experiments, p62 expression was only significantly reduced in hypoxic MMEC and not in HUVEC (Fig. 2d) . The overall results indicate that HUVEC are more prone to apoptosis and less predisposed to autophagy than MMEC, supporting the hypothesis that MMEC are more resistant to hypoxia-induced cell death than HUVEC.
Hypoxia-induced responses are more evident in MMEC than in HUVEC
Hypoxia seems to affect MMEC and HUVEC proliferative and apoptotic profiles differently. To determine whether these observations were associated with different adaptive responses to hypoxia we evaluated the hypoxic signature in both cell types. Previous reports have shown that MMEC express higher protein levels of HIF-1α than do HUVEC under normoxic conditions [15] . As shown in Fig. 3a , expression of HIF-1α was significantly higher in MMEC than in HUVEC under hypoxia. We then analyzed the gene expression profile associated showed that under hypoxia, CAIX, GLUT-1 and MCT-4 mRNA levels were significantly higher than in normoxic controls and more evident in MMEC than in HUVEC ( Fig. 3b-d) .
Among genes uniquely regulated by HIF-1α at transcriptional level, BNIP3 is involved in a program exploited by several cell types to survive hypoxic insult [21] . Like HIF-1α, BNIP3 is highly expressed in MMEC under normoxic conditions [22] . As shown in Fig. 4a, BNIP3 was expressed more in MMEC than in HUVEC at mRNA and protein levels. To further analyze this observation, we performed kinetic experiments that showed an evident difference in BNIP3 expression profile in the two cell types (Fig. 4b) . As expected, mRNA levels of BNIP3 were always higher under hypoxic conditions in both cell types. In HUVEC, exposure to hypoxia caused a modest increase in BNIP3 expression, which was enhanced at 8 h and then declined at 24 h and 48 h. In contrast, in MMEC we observed an initial sharp increase in BNIP3 mRNA expression at 8 h which was further increased at 24h and 48 h. These results clearly indicate that MMEC tend to adapt to hypoxia more efficiently than HUVEC and that BNIP3 expression may play a role in cell survival. 
Inhibition of BNIP3 reduces HUVEC survival under hypoxia
Previous reports established a role of BNIP3 in adaptation to hypoxia by several cell types [21] . It has also been reported that ablation of BNIP3 in cells where it is overexpressed (e.g. MMEC) promoted apoptosis [22] . To better establish the role of BNIP3 in EC survival under hypoxic conditions, we evaluated proliferation and apoptosis/autophagy in HUVEC in which BNIP3 was inhibited by siRNA technology. As shown in Fig. 5a , inhibition of BNIP3 resulted in a significant reduction of BNIP3 expression at mRNA (more than 90%) and protein levels, under normoxic and hypoxic conditions. Inhibition was associated with a reduction in cell proliferation (Fig. 5b) and enhancement of apoptosis (Fig. 5c ). In contrast with the results obtained in hypoxic MMEC, where BNIP3 was overexpressed, BNIP3 inhibition in hypoxic HUVEC resulted in a reduction in the autophagic process. Indeed, the LC3B-II/LC3B-I ratio was significantly lower in hypoxic HUVEC, where BNIP3 was silenced, than in hypoxic controls (Fig. 5d) . Again our results indicate a crucial role of BNIP3 not only in the survival of pathological and highly proliferative EC (i.e. MMEC) but also of normal quiescent EC (i.e. HUVEC) in a hypoxic microenvironment. 
Discussion
Several reports have indicated that EC are particularly resistant to hypoxic stress. Compared to other primary cell lines, including neurons and cardiomyocytes, EC only die after prolonged exposure to hypoxia [10] . Previous studies show that EC from tumor vessels are functionally different from quiescent EC, in line with the increased angiogenesis involved in tumor progression [23, 24] . We sought to compare the adaptive responses to hypoxia of EC from healthy quiescent vessels (HUVEC) and from tumor vessels (MMEC). This is the first report that MMEC are more resistant than HUVEC to hypoxic stress in terms of cell viability, being more prone to autophagy and less predisposed to apoptosis. The fact that MMEC were less prone to apoptosis was clarified by previous studies, which, however, were conducted under normoxic conditions [22] . In our study, we determined that HUVEC were less resistant than MMEC to cell death due to prolonged exposure to hypoxia. Indeed, short exposure to hypoxia failed to induce cell death in either cell type. This is consistent with previous observations showing that HUVEC are resistant to hypoxia-induced cell death after 24 h of exposure [10] . However, while HUVEC were less viable after 48 h of hypoxic treatment, MMEC continued to resist. Compared with HUVEC, MMEC expressed a higher level of livin and cdc25A and a lower level of p21. This is in line with previous reports indicating that downregulation of cdc25 and upregulation of p21 expression in EC correlates with cell cycle arrest [25, 26] . With regard to livin, an inhibitor of apoptosis proteins, our observations show that its expression is positively correlated with cell survival [27] . Our results are also in agreement with previous reports indicating that hypoxia-induced death of HUVEC could be attributed to apoptosis [10] . However, the latter authors did not find any apparent correlation with alterations in Bax and Bcl-xl proteins. In our hands, such alterations were only relatively significant after 48 h of hypoxia. More interestingly, in hypoxic MMEC, Bax/ Bcl-xl expression was significantly reduced, in line with the hypothesis that MMEC are more resistant to hypoxia-induced cell death. It is important to underline the significant reduction in Beclin-1 expression and in the LC3B-II/LC3B-I ratio in hypoxic HUVEC. Beclin-1 is a major agent and initiator of autophagy [7] and when autophagy is activated, cytoplasmic LC3B-I protein is cleaved, lipidated and inserted into autophagosome membranes as LC3-II [28] . Thus an increase in the amount of the smaller molecular weight LC3-II protein and an increase in the LC3-II/LC3-I ratio are a hallmark of autophagy and correlated with an increased number of autophagosomes. Autophagy is also associated with p62 degradation [20] and indeed here we found that hypoxic MMEC expressed lower p62 levels. As previously shown, autophagy may be considered a pro-survival adaptive response in several cell types [8, 21, 29] . This may further explain why HUVEC are less resistant to hypoxia-induced cell death than MMEC, which in comparison appeared to be more prone to autophagy.
Previous reports clearly illustrate how cells adapt to hypoxia by expression of genes closely regulated by HIF-1α, including CAIX, GLUT-1, MCT-4 and BNIP3, in order to survive in a hostile microenvironment [30] [31] [32] [33] . The fact that HUVEC tended to accumulate less HIF-1α than MMEC, and that MMEC expressed higher mRNA levels of CAIX, GLUT-1, MCT-4 and BNIP3 than HUVEC, supports the hypothesis that MMEC show a better metabolic and autophagic adaptive response to hypoxic stress. Indeed, BNIP3 has been described as a key molecule induced by hypoxia and involved in the autophagic switch enabling cells to survive and to avoid apoptosis [21] . Our results fully agree with previous reports demonstrating that hypoxia-induced autophagy is a survival process and is linked to the expression of BNIP3 and BNIP3like (BNIP3L) [7] . The same authors report that ectopic expression of BNIP3 and BNIP3L triggers autophagy under normoxic conditions. It should be underlined that MMEC overexpress BNIP3 even under normoxia [22] and our results clearly define its overexpression in MMEC under hypoxic conditions. The proposed protective role of BNIP3 in EC exposed to hypoxia is further corroborated by the fact that when BNIP3 was silenced in HUVEC, we observed lower viability and increased apoptosis. This is in line with a previous study showing that increased apoptosis occurs when BNIP3 is inhibited in MMEC [22] . In Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry
